Characterization of innate lymphoid cell subsets infiltrating melanoma and epithelial ovarian tumors
Douglas C. ChungMaryam GhaediKathrin WarnerAzin SayadSamuel D. SaibilMarcus Q. BernardiniBlaise A. ClarkePatricia A. ShawMarcus O. ButlerAlexandra EassonSorana MorrissyBen X. WangLinh NguyenPamela S. OhashiNicolas Jacquelota Princess Margaret Cancer Centre,University Health Network,University of Toronto,Toronto,ON,Canadab Department of Immunology,University of Toronto,Toronto,ON,Canadac Division of Gynecologic Oncology,University Health Network,Toronto,ON,Canadad Department of Laboratory Medicine and Pathobiology,University Health Network,University of Toronto,Toronto,ON,Canadae Department of Surgical Oncology,University Health Network,Toronto,ON,Canadaf Department of Biochemistry and Molecular Biology,Cumming School of Medicine,University of Calgary,Calgary,AB,Canadag The Riddell Centre for Cancer Immunotherapy,Arnie Charbonneau Cancer Research Institute,Calgary,AB,Canadah Department of Microbiology,Immunology and Infectious Disease,Cumming School of Medicine,University of Calgary,Calgary,AB,Canada
DOI: https://doi.org/10.1080/2162402x.2024.2349347
2024-05-10
OncoImmunology
Abstract:The innate lymphoid cell (ILC) family is composed of heterogeneous innate effector and helper immune cells that preferentially reside in tissues where they promote tissue homeostasis. In cancer, they have been implicated in driving both pro- and anti-tumor responses. This apparent dichotomy highlights the need to better understand differences in the ILC composition and phenotype within different tumor types that could drive seemingly opposite anti-tumor responses. Here, we characterized the frequency and phenotype of various ILC subsets in melanoma metastases and primary epithelial ovarian tumors. We observed high PD-1 expression on ILC subsets isolated from epithelial ovarian tumor samples, while ILC populations in melanoma samples express higher levels of LAG-3. In addition, we found that the frequency of cytotoxic ILCs and NKp46 + ILC3 in tumors positively correlates with monocytic cells and conventional type 2 dendritic cells, revealing potentially new interconnected immune cell subsets in the tumor microenvironment. Consequently, these observations may have direct relevance to tumor microenvironment composition and how ILC subset may influence anti-tumor immunity.
oncology,immunology